Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon Allaire

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF CohortManon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/BevacizumabClaudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
European Journal of Gastroenterology & Hepatology|August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapyEric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to ImmunotherapyCong Trung Nguyen, Stefano Caruso, Pascale Maille, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2018
Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control studyManon Allaire, Jean-François D Cadranel, Christophe Bureau, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF CohortMarie Decraecker, Héloïse Bourien, Elhadji Malick Thiam, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2018
The epidemiology of Budd-Chiari syndrome in FranceIsabelle Ollivier-Hourmand, Manon Allaire, Nathalie Goutte, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradicationManon Allaire, Pierre Nahon, Richard Layese, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF CohortManon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/BevacizumabClaudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
European Journal of Gastroenterology & Hepatology|August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapyEric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to ImmunotherapyCong Trung Nguyen, Stefano Caruso, Pascale Maille, et al.
European Journal of Gastroenterology & Hepatology|May 5, 2018
Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control studyManon Allaire, Jean-François D Cadranel, Christophe Bureau, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF CohortMarie Decraecker, Héloïse Bourien, Elhadji Malick Thiam, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2018
The epidemiology of Budd-Chiari syndrome in FranceIsabelle Ollivier-Hourmand, Manon Allaire, Nathalie Goutte, et al.
Hepatology (Baltimore, Md.)|April 18, 2018
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradicationManon Allaire, Pierre Nahon, Richard Layese, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Pageof 9